Introduction {#sec1_1}
============

Obesity is now considered a major public health concern globally as it predisposes to a number of chronic human diseases \[[@B1]\]. The major cause of obesity is a positive energetic balance resulting from an increased energy intake from the diet and a decreased energy output associated with low physical activity \[[@B2],[@B3]\]. However, obesity is a complex chronic disorder with a multifactorial etiology, involving genetics, hormones, diet, and environment \[[@B4]\]. In addition, recent studies have focused on intestinal microbiota as environmental factors that increase energy yield from diet, regulate peripheral metabolism, and thereby increase body weight \[[@B5]\].

The gut microbiota contains approximately 10^12^ cells/g of feces. However, the composition of gut microbiota can vary among humans, according to age, food habits and environmental factors, and the vast majority of microorganisms belong to the phyla of Firmicutes (Gram-positive), Bacteroidetes (Gram-negative), Actinobacteria (Gram-positive), and Proteobacteria (Gram-negative) \[[@B4],[@B6]\]. The Firmicutes is the largest bacterial phylum and contains more than 200 genera, including *Lactobacillus*, *Mycoplasma*, *Bacillus,* and *Clostridium*. The Bacteroidetes includes the genus *Bacteroides* (limited to species within the *Bacteroides fragilis* group). The Actinobacteria including the genus *Bifidobacterium* (considered as probiotic) and the Proteobacteria belong to a variety of pathogenic bacteria (e.g. *Escherichia coli*) \[[@B5],[@B7]\].

Several studies reported that obesity is associated with a low abundance of intestinal Bacteroidetes and a high abundance of Firmicutes \[[@B8],[@B9],[@B10]\]. However, these findings are in disagreement with two other more recent human studies \[[@B11],[@B12]\], which showed that no difference was found in the proportions of Bacteroidetes and Firmicutes in the feces of lean and obese subjects.

Even though the exact role of gut bacteria in obesity development is still obscure, it has been proposed that changes in gut microbiota composition in response to high-fat diets affect lipogenesis, gut permeability for lipopolysaccharides (LPS), and the inflammatory status as well as the endocannabinoid system tone \[[@B13]\].

The LPS found in the outer membrane of Gram-negative bacteria act as endotoxins and can elicit strong immune responses. LPS are large glycolipids that consist of lipid and polysaccharide fractions joined by a covalent bond. The lipid A is a phosphorylated glucosamine disaccharide acylated with hydroxyl-saturated fatty acids one of which anchors in the bacterial membrane. It is responsible for much of the toxicity of Gram-negative bacteria. The core oligosaccharide attaches directly to lipid A. The O antigen, a repetitive glycan polymer, is attached to the core oligosaccharide and comprises the outermost domain of the LPS molecule \[[@B14]\]. LPS in *Bacteroides fragilis* has an unusual structure and is 10 to 1,000 times less toxic than that of *E. coli* \[[@B7]\]. It is claimed that gut microbiota composition can affect the host homeostasis modulating subclinical systemic inflammation \[[@B2],[@B14]\].

An increased level of LPS in obese individuals is mostly due to processes involving the transport of LPS from the gut to the blood, e.g., increase in chylomicron-driven transport of LPS, a rupture of the gut barrier integrity leading to abnormal gut permeability, and a decrease in processes involved in intestinal LPS degradation (alkaline phosphatase activity). Once LPS reach blood circulation, they cause metabolic endotoxemia, which thereby activates the macrophages in the different tissues leading to a low-level inflammation being part of the metabolic alterations occurring upon obesity \[[@B2],[@B15]\]. In the adipose tissue, LPS trigger inflammation by inducing release of pro-inflammatory and chemotactic molecules from local macrophages and preadipocytes \[[@B14]\].

The objective of this study was to investigate the relationship between major bacterial groups of gut microbiota, the LPS levels and the metabolic profile in young obese and normal-weight subjects. In this study, real-time PCR was used to quantify the main groups of gut microbiota, establishing the basis for subsequent studies, focusing on the gut microbiota composition which might be a novel target for treating chronic diseases.

Material and Methods {#sec1_2}
====================

Participants {#sec2_1}
------------

The subjects were selected during the period of June to November 2012 in Chilpancingo, a city localized in Southern Mexico. Participants were both of sexes and aged between 18 and 25 years. Body weight was measured in light clothes without shoes using a Tanita BC-553. Body circumference was measured using a diameter tape and height was measured using a stadiometer. The Research Ethics committee of Guerrero University approved the study; all participants agreed to participate in the study by means of informed consent in writing and completed the questionnaire about history/lifestyle. They were classified into two study groups, with 32 obese (BMI ≥ 30 kg/m^2^) and 32 normal-weight (BMI = 18.5-24.9 kg/m^2^) subjects. No antibiotics had been taken in the 4 weeks prior to study by any of the youth. Subjects with probiotic and prebiotic supplementation, hypocaloric diets, and chronic and infectious disease as well as pregnant women were excluded.

Laboratory Measurements {#sec2_2}
-----------------------

A fasting blood sample was obtained from each youth for the measurement of the following parameters. Glucose, cholesterol, triglyceride, HDL-cholesterol and LDL-cholesterol levels were obtained using a standard protocol of Spinreact (Girona, Spain). Endotoxin units were determined using Limulus Amebocyte Lysate kit (QCL-1000, Lonza, MD, USA); FDA-approved, endotoxin standard solution was prepared at concentrations ranging from 0.1 to 1.0 UE/ml to construct a standard curve. The absorbance from each microplate well was measured at 405 nm (TECAN 3500, Grödig, Austria).

Gut Microbiota Analysis {#sec2_3}
-----------------------

The DNA extractions from pure cultures of the control strain and fecal samples were extracted by using the QIAamp DNA stool Mini kit (Qiagen, Hilden, Germany). To characterize gut microbiota, PCR primers were used to target different species or groups of gut microbiota (table [1](#T1){ref-type="table"}). Quantitative PCR (qPCR) was conducted as previously described \[[@B12],[@B16],[@B17],[@B18]\]. Briefly, the amplification and detection were performed with a 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Each reaction mixture of 25 μl was composed of SYBR Green qPCR Master Mix (Applied Biosystems), 1 μl of each of the specific primers at a concentration of 0.25 μmol/l, and 1 μl of template DNA (10-30 ng). The fluorescent products were detected at the last step of each cycle. A melting curve analysis was made after amplification to distinguish the targeted PCR product from the non-targeted PCR product. A curve standard was done using the *E. coli.* reference strain ATCC 25922. ATCC 25922 was added in serial dilutions from 5 × 10^6^ to 5 × 10^2^ cells to a series of PCR mixtures with *E. coli* -specific primers.

Statistical Analysis {#sec2_4}
--------------------

The descriptive analysis was performed using frequencies and chi square test for categorical variables. Parametric variables were reported as mean and standard deviation, the significance of differences between groups was determined using Student\'s t test. Non-parametric data were expressed as medians and percentiles (25th and 75th), statistical differences were determined using the Mann-Whitney U test. Spearman\'s correlation coefficients were computed to assess the associations between some variables in all youths. Kruskal-Wallis test were used to find differences between Gram-negative bacteria and LPS. Statistical analysis was done using STATA software (V.11; College Station, TX, USA), and p \< 0.05 was reported as statistically significant.

Results {#sec1_3}
=======

Subject Characteristics {#sec2_5}
-----------------------

The mean age of the youths studied was 21 years, with homogeneous distribution by sex. In the obese group, 29 were healthy and 3 had metabolic syndrome. Obese youths had a BMI of 34.5 (32.9-36.45) kg/m^2^, triglycerides, cholesterol, LDL-cholesterol, body temperature, and waist circumference were significantly larger in obese youths when compared with normal-weight group. Glucose and HDL-cholesterol values were normal in both groups. Serum LPS levels in obese and normal-weight youths were 1.22 (0.96-1.51) endotoxin units (EU)/ml and 1.14 (0.72-1.31) EU/ml, respectively (table [2](#T2){ref-type="table"}). Correlation of clinical and biochemical variables demonstrated that only body temperature and BMI were positively correlated (r = 0.387, p = 0.001).

Quantification of Gut Microbiota {#sec2_6}
--------------------------------

The total bacteria numbers in fecal samples were higher in normal-weight youths (11.0 log~10~ cell/g) than in obese youths (10.7 log~10~ cell/g; p = 0.046). However, obese youths have larger numbers of *Clostridum leptum* and *Lactobacillus* (p \< 0.001), and lower numbers of *Prevotella* and *E. coli* (p \< 0.001). The amounts of *B. fragilis* and *Bifidobacterium* did not differ between both study groups (table [3](#T3){ref-type="table"}).

Gram-positive bacterial species the counts of which differed statistically or tended to differ between lean and obese individuals were included in the correlation analyses with clinical and biochemical variables. Only, *C. leptum* showed positive correlation with BMI (r = 0.414, p = 0.007) and triglycerides (r = 0.306, p = 0.013), which may be involved in weight gain.

Correlation between LPS, Clinical Variables and Gram-Negative Bacteria {#sec2_7}
----------------------------------------------------------------------

The LPS levels tended to positively correlate with BMI being higher in obese youths (r = 0.46, p = 0.008) than in the normal-weight group (r = 0.30, p = 0.092). Regarding triglycerides, also a positive correlation was observed (fig. [1](#F1){ref-type="fig"}). Body temperature, cholesterol, and LDL-cholesterol showed negative correlations with LPS levels.

LPS levels were slightly higher in women 1.20 EU/ml (0.85-1.52) than in men 1.16 EU/ml (0.97-1.35), although this difference was not statistically significant. However, LPS levels showed positive correlation with waist circumference in women (r = 0.34, p = 0.04). Also, triglycerides showed positive correlation with LPS levels in women (fig. [2](#F2){ref-type="fig"}).

We also assessed the correlation between Gram-negative bacteria and LPS levels (tertiles). A positive correlation was only found for *E. coli*, with the second tertile (1-1.3 EU/ml) presenting fewer bacteria compared to the first and third tertiles (table [4](#T4){ref-type="table"}). In contrast, *Prevotella* and *B. fragilis* showed negative correlations. Since Gram-negative bacteria of gut microbiota are related to subclinical metabolic endotoxemia, we analyzed the relative risks of the different bacterial species. A low number of *E. coli* comes along with a greater risk of having high LPS levels (OR = 4.378, p = 0.005) which could not be shown for *Prevotella* and *B. fragilis*.

Discussion {#sec1_4}
==========

There is growing awareness of the importance of gut microbioma for health and disease and recognition that the microbe-to-host metabolic signaling is crucial to understand the mechanistic basis of their interaction \[[@B19]\]. In the present study, biochemical and anthropometric parameters for two study groups were determined. As expected, obese youths have high total cholesterol levels, LDL-cholesterol and triglycerides as well as a larger waist circumference and a higher body temperature. These variables indirectly reflect that the obese patients do not have a healthy lifestyle and that they are prone to suffer from metabolic disease in the long term.

In this study, we found an association between body temperature and BMI. This may be due to the fact that adipose tissue increases the synthesis and secretion of leptin that informs the brain of body fat levels. Via hypothalamus-adipose tissue crosstalk, neuropeptide Y stimulates food intake and white fat deposition and at the same time reduces brown fat activation and consequently thermogenesis \[[@B20]\].

The gut microbiota has been identified as a potential contributor to metabolic disease. It has been shown that obese individuals present different proportions of bacterial phyla compared with lean individuals, with an increase of Firmicutes and Actinobacteria and a decrease in Bacteroidetes \[[@B21]\]. We found a lower total bacteria count in obese youths compared with normal-weight subjects. Santacruz et al. \[[@B22]\] reported significant differences in total bacteria counts in fecal samples of low- and high-weight loss groups of adolescents before and after intervention based on an energy-restricted diet. In our opinion, this could be due to lower fiber but higher fat consumption and a greater prevalence of constipations in obese subjects \[[@B23]\]. The count of Gram-positive bacteria (*C. leptum* group and *Lactobacillus*) was higher in obese individuals, a result similar to those of Ley et al. \[[@B8]\] in 2006 and Armougom et al. \[[@B10]\] in 2009. These observations reinforce the possibility of a role of the Fimicutes in weight gain. In addition, significant statistical associations of the *C. leptum* group with high levels of triglycerides and BMI were found. In a gnotobiotic mouse model, the obesogenic properties of *Clostridium ramosum* were demonstrated by showing that this organism promotes body fat accumulation by enhancing intestinal glucose and lipid absorption \[[@B24]\].

The Gram-negative bacteria (*E. coli* and *Prevotella*) were lower in obese than in normal-weight youths. In a recent study, the absence of *E. coli* was an independent predictor of weight gain (OR = 10.7. Strikingly, patients with an 18% BMI increase showed a dramatic increase of *Lactobacillus reuteri* but no increase of *E. coli* \[[@B25]\]. These data may indicate the protective role of *E. coli*. Even though the *B. fragilis* cells numbers were constant in both study groups, the phylum *Bacteroidetes* has been associated with weight loss. Proposed mechanisms linking the microbiota to fat content and weight include differential effects of bacteria on the efficiency of energy extraction from the diet and changes in host metabolism of absorbed calories \[[@B26]\].

LPS is the most potent antigenic component of the Gram-negative bacterial cell wall and modulates the expression of various pro-inflammatory cytokines, activates production of lysosomal enzymes, and increases phagocytosis \[[@B27]\]. Thus, LPS may play a role in the low-grade inflammation and insulin resistance, which can be observed in obesity. A high-fat diet also seems to increase the intestinal absorption of LPS, commonly known as metabolic endotoxemia \[[@B6],[@B13],[@B21]\]. In this study, we observed that the LPS level was higher in obese than in normal-weight subjects. Even if no significant difference was observed, these results are not congruent with previous studies. This may be due to smaller amount of Gram-negative bacteria (*Prevotella* and *E. coli*) in obese than in normal-weight subjects. LPS are constantly released within the gut by the lysis of Gram-negative bacteria, making them available for absorption into the bloodstream \[[@B15]\]. Thus it is conceivable that the differences observed may lead to significantly increased LPS blood levels in obese subjects in the future.

On the other hand, we observed that the increase of LPS levels positively correlate with triglyceride levels and BMI. These results suggest that fat was more efficient in transporting bacterial LPS from the gut lumen into the bloodstream, and adds to the knowledge of mechanisms responsible for relation between food intake and metabolic diseases as experimental data were found in apparently healthy men \[[@B28]\]. A study in Gambian women showed evidence for metabolic endotoxemia in obese and diabetic participants \[[@B29]\]. In our study increased LPS levels were accompanied by increased triglyceride levels and waist circumference in young obese females possibly reflecting an enhanced fat absorption and storage capacity in women compared to men.

This is in agreement with our findings that a low number of fecal *E. coli* is accompanied by higher LPS concentrations in the blood (1-1.3 EU/ml). On the other hand, this connection could not be verified for *B. fragilis*; however, this bacterium has a different LPS and is less toxic. Research about *Prevotella bivia* cell lysates isolated from the vagina resulted in higher LPS concentrations (10,713.0 ± 206.5 EU/ml) than *E. coli* (4,679.0 ± 585.3 EU/ml) or *Gardnerella vaginalis* (0.07 ± 0.01 EU/ml of LPS) \[[@B30]\]. However, in this study *Prevotella* showed low risk in second tertile of endotoxemia (1-1.3 EU/ml). Further studies are required to determine the role of Gram-negative bacteria in producing LPS that modulate the expression of various pro-inflammatory cytokines in obesity. Thus it is known that other Gram-negative bacteria which were not investigated in the present study, particularly Proteobacteria as well as *Enterobacter* genera, induced obesity in mice, showed increased serum endotoxin load, and aggravated inflammatory conditions \[[@B31]\].

The limitations of this study include the relatively small sample size of groups. Moreover, we made no dietary survey to evaluate macronutrient consumption in order to establish the association of gut microbiota with the diet and absorbed calories. However, this study confirmed and complemented the results of the role of gut microbiota in the obese by using molecular techniques that target specific bacterial groups.

In conclusion, subclinical metabolic endotoxemia determined by serum concentrations of LPS was related to a smaller amount of *E. coli*, high triglyceride levels, and central adiposity in obese youths.
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###### 

Sequence of primers for real-time PCR

  ------------------------------------------------------------------------------------
  Target                    Sequence                 Size (bp)   Tm (°C)   Reference
  ------------------------- ------------------------ ----------- --------- -----------
  Total bacteria            ACTCCTACGGGAGGCAGCAGT\   600         60        12
                            ATTACCGCGGCTGCTGGC                             

                                                                           

  Firmicutes                                                               

   *Clostridium leptum*     GCACAAGCAGTGGAGT\        239         50        16
                            CTTCCTCCGTTTTGTCAA                             

   *Lactobacillus*          TACATCCCAACTCCAGAACG\    90          55        17
                            AAGCAACAGTACCACGACC                            

                                                                           

  Bacteroidetes                                                            

   *Bacteroides fragilis*   ATAGCCTTTCGAAAGRAAGAT\   495         50        16
                            CCAGTATCAACTGCAATTTTA                          

   *Prevotella*             CACRGTAAACGATGGATGCC\    513         55        16
                            GGTCGGGTTGCAGACC                               

                                                                           

  Bacteroidetes                                                            

   *Bifidobacterium*        CTCCTGGAAACGGGTGG\       550         55        16
                            GGTGTTCTTCCCGATATCTACA                         

                                                                           

  Protobacteria                                                            

   *Escherichia coli*       CATGCCGCGTGTATGAAGAA\    95          55        18
                            CGGGTAACGTCAATGAGCAAA                          
  ------------------------------------------------------------------------------------

###### 

Clinical and biochemical characteristics of the study subjects

  -------------------------------------------------------------------------------------------------------------------
                                                             Normal weight\        Obese\                 p value
                                                             (n = 32)              (n = 32)               
  ---------------------------------------------------------- --------------------- ---------------------- -----------
  Age[^a^](#T2F1){ref-type="table-fn"}, years                21.06 ± 1.93          21.43 ± 1.93           0.443

  Sex [^b^](#T2F2){ref-type="table-fn"}, %                                                                

   Female                                                    19 (59.38)            16 (50.0)              0.451

   Male                                                      13 (40.63)            16 (50.0)              

  BMI[^c^](#T2F3){ref-type="table-fn"}, kg/m^2^              21.35 (19.85--22.8)   34.5 (32.9--36.45)     \<0.001\*

  Waist circumference[^c^](#T2F3){ref-type="table-fn"}, cm   78.75 (73.6--81)      108.5 (102.6--116.1)   \<0.001\*

  Temperature[^c^](#T2F3){ref-type="table-fn"}, °C           35.85 (35.5--36.45)   36.3 (36.15--36.75)    0.001\*

  Glucose[^c^](#T2F3){ref-type="table-fn"}, mg/dl            81 (75--84.5)         80 (74.5--87.5)        0.999

  Cholesterol[^c^](#T2F3){ref-type="table-fn"}, mg/dl        142 (109.5--165)      168 (151--194.5)       \<0.001\*

  HDL-cholesterol[^c^](#T2F3){ref-type="table-fn"}, mg/dl    44.5 (38--55.5)       44 (37--55)            0.772

  LDL-cholesterol[^c^](#T2F3){ref-type="table-fn"}, mg/dl    96.5 (80.5--119.5)    114 (107--149.5)       0.002\*

  Triglycerides[^c^](#T2F3){ref-type="table-fn"}, mg/dl      70 (58.5--89.5)       123 (95.5--156.5)      \<0.001\*

  LPS[^c^](#T2F3){ref-type="table-fn"}, EU/ml                1.14 (0.72--1.31)     1.22 (0.96--1.51)      0.210
  -------------------------------------------------------------------------------------------------------------------

Mean ± SD, Student\'s t test.

n (%) chi square test.

Median (25th and 75th percentile) Mann-Whitney U test, statistical difference (p \< 0.050).

###### 

Gut microbiota in obese and normal-weight young subjects[^a^](#T3F1){ref-type="table-fn"}

  ----------------------------------------------------------------------------------------------------------------------
                       Normal weight\              Obese\                      p value
                       (log~10~ cell/g of fecal)   (log~10~ cell/g of fecal)   
  -------------------- --------------------------- --------------------------- -----------------------------------------
  Total bacteria       11.0 (10.6--11.2)           10.7 (10.4--11.0)           0.046[\*](#T3F1){ref-type="table-fn"}

                                                                               

  Gram-positive                                                                

   *C. leptum*         8.2 (7.5--8.3)              8.9 (8.3--8.9)              \<0.001[\*](#T3F1){ref-type="table-fn"}

   *Lactobacillus*     6.4 (6.2--6.4)              6.9 (6.6--6.9)              \<0.001[\*](#T3F1){ref-type="table-fn"}

   *Bifidobacterium*   7.1 (6.1--7.9)              6.8 (5.9--7.8)              0.527

                                                                               

  Gram-negative                                                                

   *B. fragilis*       9.2 (8.5--9.6)              8.7 (7.0--9.8)              0.148

   *Prevotella*        9.0 (7.2--9.4)              7.6 (6.1--7.6)              \<0.001[\*](#T3F1){ref-type="table-fn"}

   *E. coli*           9.7 (8.8--10.1)             8.5 (7.7--9.0)              \<0.001[\*](#T3F1){ref-type="table-fn"}
  ----------------------------------------------------------------------------------------------------------------------

Median (25th and 75th percentile) Mann-Whitney U test.

Statistical difference (p \< 0.050).

###### 

Gram-negative bacteria and metabolic endotoxemia[^a^](#T4F1){ref-type="table-fn"}

  Gram-negative bacteria   \<1 EU/ml (n = 21)   1--1.3 EU/ml (n = 21)   \>1.3 EU/ml (n = 22)   p value
  ------------------------ -------------------- ----------------------- ---------------------- ---------------------------------------
  *E. coli*                9.43 (8.82--9.97)    8.63 (8.09--9.07)       9.28 (8.63--9.44)      0.036[\*](#T4F2){ref-type="table-fn"}
  *Prevotella*             7.05 (6.4--7.39)     7.12 (6.4--7.39)        7.37 (6.4--7.39)       0.789
  *B. fragilis*            8.95 (8.47--9.01)    8.57 (7.52--9.16)       9.02 (8.57--9.96)      0.526

Median (25th and 75 th percentile) log~10~ cell/goffecal.

Kruskal-Wallis test (p \< 0.050).
